Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06424197 · ClinicalTrials.gov registry record · NA
Colorectal Cancer Screening Intervention Study
A NA study, sponsored by Oakland University.
- Completed
- Registry status
- NA
- Development phase
- 799
- Enrollment target
NCT06424197 is a NA study that has completed, run by Oakland University. The registered enrollment target is 799 participants.
The verdict
NCT06424197, a NA study, has completed, sponsored by Oakland University.
- COMPLETED
- Registry status
- NA
- Development phase
- 799 participants
- Enrollment target
Study Summary
Colorectal cancer (CRC) is one of the leading causes of cancer mortality in the United States, and African Americans (AfAms) still fare worse in CRC incidence and mortality compared to European Americans (EuAms). We propose to examine whether combining both fear-reduction and racially-targeted norm-based messages will increase at-home stool-based CRC screening receptivity and uptake for all African American regardless of level of racial identity. Given low return rates of at-home screening kits, we will also explore whether making an explicit commitment to return screening kits is associated with increased kit returns.
Interventions
- OTHER Racial group-targeted messages
- OTHER Explicit Commitment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 799 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06424197
The ClinicalTrials.gov registry entry for NCT06424197 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 799 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oakland University, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Racial group-targeted messages is the first listed.
NCT06424197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06424197 about?
NCT06424197 is a clinical study titled "Colorectal Cancer Screening Intervention Study". Colorectal cancer (CRC) is one of the leading causes of cancer mortality in the United States, and African Americans (AfAms) still fare worse in CRC incidence and mortality compared to European Americans (EuAms). We propose to examine whether combining both fear-reduction and racially-targeted norm-...
What is the current status of trial NCT06424197?
This trial is currently completed. It is a NA study. The enrollment target is 799 participants. The study started on 2023-03-01. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT06424197?
The interventions under investigation include: Racial group-targeted messages (OTHER), Explicit Commitment (OTHER).
Who is sponsoring clinical trial NCT06424197?
This trial is sponsored by Oakland University, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.